Cinemark Holdings Sees Reduced Estimates and 4 Stock Analyses to Eye

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

MELA Sciences, Inc. (NASDAQ:MELA) has been labeled Stephens’s best idea following channel checks that suggested an early launch of the company’s MelaFind technology, as it seems to be making great progress. Stephens thinks MELA shares are pricing with not much chance of commercial success, and the firm believes that there is minimal downside currently. The firm maintains its Overweight rating and $10 price target on the stock.

PSS World Medical Inc. (NASDAQ:PSSI) has received positive comments by UBS after the stock’s sell-off due to a negative blog post.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Ctrip.com International Ltd. (NASDAQ:CTRP) airticket sales are believed by CTRIP.com’s to be a challenge because of eLong’s air ticket coupon program and Qunar’s growing ticket booking volumes. Citi claims that CTRIP’s hotel booking business has seen pressure from competitor rebates. The firm maintains its Sell rating on the stock.

Cinemark Holdings Inc. (NYSE:CNK) Q3 EPS and 2012 EPS estimates were lowered to below consensus levels by Barrington, due to softer box office results than predicted for Q3. The firm keeps its Outperform rating and lowers its target to $31 from $33 on the stock.

Power-One Inc. (NASDAQ:PWER) shares have been defended by Raymond James.

Don’t Miss: Here’s Another Competitor For Netflix.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business